Condition Rating Guides

How VA Rates Prostate Conditions: BPH, Prostate Cancer, and Voiding Dysfunction Guide

VA ratings for prostate conditions are evaluated under 38 CFR 4.115a and 4.115b using Diagnostic Codes 7527 and 7528. Active prostate cancer receives a temporary 100% rating, while BPH and cancer residuals are rated on urinary frequency, voiding dysfunction, and Special Monthly Compensation (SMC-K).

Go directly to the official source

This page explains a concept. It is not the current, authoritative list. Confirm details directly with VA before relying on anything here.

Benign prostatic hypertrophy (BPH) vs. prostate cancer

The VA rates benign prostatic hypertrophy (BPH) under Diagnostic Code 7527 and malignant neoplasms of the genitourinary system (prostate cancer) under Diagnostic Code 7528. While BPH is a non-malignant enlargement that obstructs urinary flow, prostate cancer is an oncological disease. Both conditions ultimately result in urinary impairment that is evaluated under the general rating formula for voiding dysfunction.

The temporary 100% active prostate cancer rating and 6-month rule

Under DC 7528, a veteran diagnosed with active prostate cancer is entitled to a temporary 100% disability rating upon service connection. This 100% evaluation continues throughout the duration of active treatment (such as surgery, radiation therapy, brachytherapy, or chemotherapy) and extends for exactly six months following the completion of treatment, after which a mandatory re-examination determines residual disability.

Rating residuals under 38 CFR 4.115a voiding dysfunction

Following the cessation of active cancer treatment, or when evaluating BPH under DC 7527, ratings are assigned based on residual impairment under 38 CFR 4.115a. Ratings range from 10% to 60%: 10% for daytime urination every two to three hours or waking twice nightly; 20% for daytime urination every one to two hours or waking three to four times per night; 40% for daytime urination more than once an hour; and 60% for continuous catheter dependency.

Special Monthly Compensation (SMC-K) for loss of creative organ

Prostatectomy, radiation therapy, or androgen deprivation therapy often results in permanent erectile dysfunction or neurogenic impotence. In addition to any percentage disability rating for voiding dysfunction, veterans who lose the physical or functional ability to achieve an erection are eligible for Special Monthly Compensation under SMC-K (38 U.S.C. 1114(k)), which provides a monthly cash payment above their combined percentage.

PACT Act presumptive service connection for prostate cancer

Prostate cancer is listed as a presumptive condition under the PACT Act for veterans exposed to toxic burn pits and airborne hazards in the Southwest Asia theater of operations, as well as under Agent Orange presumptions for Vietnam and offshore blue water navy veterans. Qualifying veterans need only establish qualifying military service dates and a confirmed diagnosis to obtain service connection.

Related condition guides

Explore published rating criteria, evidence requirements, and diagnostic codes for related conditions.

Related guides

NEXT DIRECTIVE // PUT THIS GUIDANCE INTO ACTION

What would you like to do next?

Review CFR Criteria

Jump to the regulatory criteria section to evaluate the baseline requirements.

Review Criteria

Add to Your Claim Summary

Track this condition and calculate your whole-person combined rating.

Open Claims Binder

Calculate Combined Rating

See how multiple disability ratings combine under 38 CFR §4.25.

Calculate VA Math